A phase 1/2 study of Ad.p53 DC vaccine with indoximod immunotherapy in metastatic breast cancer

被引：1
|
作者：
Soliman, Hatem H. [1 ]
Minton, Susan E. [1 ]
Ismail-Khan, Roohi [1 ]
Han, Hyo S. [1 ]
Vahanian, Nicholas N. [2 ]
Link, Charles J. [2 ]
Kennedy, Gene [2 ]
Streicher, Howard [3 ]
Sullivan, Daniel [1 ]
Antonia, Scott J. [1 ]
机构：
[1] H Lee Moffitt Canc Ctr & Res Inst, Temple, TX USA
[2] NewLink Genet Inc, Ames, IA USA
[3] Natl Canc Inst, Bethesda, MD USA
来源：
CANCER RESEARCH | 2015年 / 75卷
关键词：
D O I：
10.1158/1538-7445.SABCS14-P2-15-04
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P2-15-04
引用
收藏
页数：2
相关论文
共 50 条
  • [1] A phase 2 study of Ad.p53 DC vaccine in combination with indoximod in metastatic solid tumors.
    Soliman, Hatem Hussein
    Minton, Susan E.
    Ismail-Khan, Roohi
    Han, Hyo S.
    Janssen, William
    Vahanlan, Nicholas N.
    Link, Charles J.
    Strelcher, Howard
    Sullivan, Daniel
    Antonia, Scott Joseph
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [2] A phase I study of ad.p53 DC vaccine in combination with indoximod in metastatic solid tumors.
    Soliman, Hatem Hussein
    Minton, Susan E.
    Han, Hyo S.
    Ismail-Khan, Roohi
    Mahipal, Amit
    Janssen, William
    Streicher, Howard
    Vahanian, Nicholas N.
    Link, Charles J.
    Ramsey, William Jay
    Antonia, Scott J.
    Sullivan, Daniel
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [3] A PHASE 2 STUDY OF DOCETAXEL IN COMBINATION WITH INDOXIMOD FOR METASTATIC BREAST CANCER
    Kennedy, E. P.
    Soliman, H. H.
    Ismail-Khan, R.
    Han, H.
    Rossi, G.
    Vahanian, N.
    Link, C.
    Sullivan, D.
    Antonia, S.
    ANNALS OF ONCOLOGY, 2014, 25
  • [4] A phase 2 study of docetaxel in combination with indoximod in metastatic breast cancer.
    Soliman, Hatem Hussein
    Minton, Susan E.
    Ismail-Khan, Roohi
    Han, Hyo S.
    Vahanlan, Nicholas N.
    Ramsey, William Jay
    Kennedy, Eugene
    Link, Charles J.
    Sullivan, Daniel
    Antonia, Scott Joseph
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [5] Immunotherapy with MUC1/CEA vaccine alone or combined with chemotherapy in patients with metastatic breast cancer
    Mohebtash, M.
    Madan, R.
    Arlen, R.
    Jacquin, J.
    Mary, P.
    Oksook, H.
    Myrna, R.
    Jeffrey, S.
    James, G.
    CANCER RESEARCH, 2009, 69 (02) : 287S - 288S
  • [6] A Phase 2 study of perifosine in advanced or metastatic breast cancer
    Natasha B. Leighl
    Susan Dent
    Mark Clemons
    Theodore A. Vandenberg
    Richard Tozer
    David G. Warr
    R. Michael Crump
    David Hedley
    Gregory R. Pond
    Janet E. Dancey
    Malcolm J. Moore
    Breast Cancer Research and Treatment, 2008, 108 : 87 - 92
  • [7] A Phase 2 study of perifosine in advanced or metastatic breast cancer
    Leighl, Natasha B.
    Dent, Susan
    Clemons, Mark
    Vandenberg, Theodore A.
    Tozer, Richard
    Warr, David G.
    Crump, R. Michael
    Hedley, David
    Pond, Gregory R.
    Dancey, Janet E.
    Moor, Malcolm J.
    BREAST CANCER RESEARCH AND TREATMENT, 2008, 108 (01) : 87 - 92
  • [8] Dendritic cell vaccine for metastatic breast cancer. Phase I/II study
    Moviglia, Gustavo A.
    Gaeta, Carlos
    Varela, Gabriela
    Farina, Fablo
    Moya, Roberto
    Paes de Lima, Andrea
    Costanzo, Herman
    Maranon, Gonzalo
    Merino, Silvia
    Guerra, O. M.
    ANNALS OF ONCOLOGY, 2004, 15 : 40 - 40
  • [9] A phase I study of an MVA vaccine targeting p53 in cancer.
    Chung, Vincent M.
    Hardwick, Nicola
    Ellenhorn, Joshua D. I.
    Espenschied, Jonathan R.
    Lim, Dean
    Chu, Peiguo
    Qian, Dajun
    Kim, Joseph
    Chao, Joseph
    Fakih, Marwan
    Yen, Yun
    Diamond, Don J.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [10] A phase 2 randomized trial of the 100 pathway inhibitor indoximod in combination with taxane based chemotherapy for metastatic breast cancer: Preliminary data
    Tang, S-C
    Montero, A.
    Munn, D.
    Link, C.
    Vahanian, N.
    Kennedy, E.
    Soliman, H.
    CANCER RESEARCH, 2016, 76
12345